文献速递中药与中成药合理使用中医内科

复方头花蓼提取物与环丙沙星的药代动力学相互作用

Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment with Polygonum capitatum Buch.-Ham. ex D. Don extracts.
PubMed 文献 · Front Pharmacol · 2022-10-25

本研究通过健康人随机三周期交叉试验和大鼠实验,探讨头花蓼提取物(PCE)与环丙沙星(CIP)联用时的药代动力学相互作用。结果显示,联用PCE使人和大鼠体内CIP全身暴露量降低约40%-50%,并改变CIP在大鼠组织中的分布;CIP对PCE标志物影响较小。体外实验提示多种转运体介导了该相互作用。

要点

  • PCE与CIP联用可使人CIP全身暴露量降低约40%-50%。
  • 大鼠中PCE增加CIP在前列腺和睾丸分布,降低肝肺分布。
  • 临床联用需关注PCE对CIP疗效和安全性的潜在影响。

核心结论

  • 多种转运体介导的草药-药物相互作用导致PCE降低CIP全身暴露并改变其组织分布。
  • 应关注PCE引发潜在药物相互作用的可能。

研究设计与样本

  • 健康人随机三周期交叉试验研究PCE与CIP的药代动力学相互作用。
  • 大鼠实验评估药代动力学和组织分布相互作用。
  • 体外实验评估PCE对OAT1/3、OCT2、MDR1和BCRP活性和表达的影响。

主要发现

  • 联用PCE使人和大鼠循环中CIP降低约40%-50%。
  • CIP几乎不改变循环中没食子酸(GA)和原儿茶酸(PCA)水平。
  • PCE显著增加大鼠前列腺和睾丸中CIP分布,降低肝和肺分布。
  • CIP显著增加大鼠前列腺和睾丸中GA或PCA分布,降低肾和心分布。
  • GA和PCA抑制OAT1/3,诱导MDR1和BCRP。

临床怎么用

  • 中医及中西医结合医生在联用头花蓼制剂与环丙沙星时,应警惕CIP暴露量降低可能影响疗效。
  • 对泌尿系统感染患者,联用方案需评估潜在相互作用并监测疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Combination of Polygonum capitatum Buch.-Ham. ex D. Don extract (PCE) and ciprofloxacin (CIP) was commonly prescribed in the treatment of urinary tract infections. Their pharmacokinetic herb-drug interactions (HDIs) were focused in this study to assess potential impact on the safety and effectiveness. Methods: A randomized, three-period, crossover trial was designed to study the pharmacokinetic HDI between PCE and CIP in healthy humans. Their pharmacokinetic- and tissue distribution-based HDIs were also evaluated in rats. Gallic acid (GA) and protocatechuic acid (PCA) were chosen as PK-markers of PCE in humans and rats. Potential drug interaction mechanisms were revealed by assessing the effects of PCE on the activity and expression of multiple transporters, including OAT1/3, OCT2, MDR1, and BCRP. Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%-50%) in humans and rats, while CIP hardly changed circulating GA and PCA. PCE significantly increased the tissue distribution of CIP in the prostate and testis of rats, but decreased in liver and lungs. Meanwhile, CIP significantly increased the tissue distribution of GA or PCA in the prostate and testis of rats, but decreased in kidney and heart. In the transporter-mediated in vitro HDI, GA and PCA presented inhibitory effects on OAT1/3 and inductive effects on MDR1 and BCRP. Conclusion: Multiple transporter-mediated HDI contributes to effects of PCE on the reduced systemic exposure and altered tissue distribution of CIP. More attention should be paid on the potential for PCE-perpetrated interactions.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li Z, Du X, Tian S, et al. Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment with Polygonum capitatum Buch.-Ham. ex D. Don extracts. Front Pharmacol. 2022. PMID: 36386188. doi:10.3389/fphar.2022.1033667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。